Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
66M
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
15.9M
-
Shares change
-
-1.47M
-
Total reported value, excl. options
-
$46.2M
-
Value change
-
-$4.04M
-
Number of buys
-
20
-
Number of sells
-
-28
-
Price
-
$2.90
Significant Holders of Neuronetics, Inc. - Common Stock, par value $0.01 per share (STIM) as of Q4 2023
70 filings reported holding STIM - Neuronetics, Inc. - Common Stock, par value $0.01 per share as of Q4 2023.
Neuronetics, Inc. - Common Stock, par value $0.01 per share (STIM) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.9M shares
of 66M outstanding shares and own 24.11% of the company stock.
Largest 10 shareholders include CANNELL CAPITAL LLC (2.77M shares), Archon Capital Management LLC (2.54M shares), BALYASNY ASSET MANAGEMENT L.P. (1.42M shares), VANGUARD GROUP INC (1.35M shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (1.13M shares), Kent Lake Capital LLC (1.12M shares), First Eagle Investment Management, LLC (776K shares), Millrace Asset Group, Inc. (725K shares), First Washington CORP (471K shares), and BlackRock Inc. (380K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.